These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors. Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266 [TBL] [Abstract][Full Text] [Related]
9. Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor. Meschler JP; Kraichely DM; Wilken GH; Howlett AC Biochem Pharmacol; 2000 Nov; 60(9):1315-23. PubMed ID: 11008125 [TBL] [Abstract][Full Text] [Related]
10. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat. Craft RM; Wakley AA; Tsutsui KT; Laggart JD J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934 [TBL] [Abstract][Full Text] [Related]
12. Cannabinoid CB(1) receptor antagonist rimonabant attenuates reinstatement of ketamine conditioned place preference in rats. Li F; Fang Q; Liu Y; Zhao M; Li D; Wang J; Lu L Eur J Pharmacol; 2008 Jul; 589(1-3):122-6. PubMed ID: 18534572 [TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor ligands suppress memory-related effects of nicotine in the elevated plus maze test in mice. Biala G; Kruk M Behav Brain Res; 2008 Oct; 192(2):198-202. PubMed ID: 18501975 [TBL] [Abstract][Full Text] [Related]
14. Intra-accumbal blockade of endocannabinoid CB1 receptors impairs learning but not retention of conditioned relief. Bergado Acosta JR; Schneider M; Fendt M Neurobiol Learn Mem; 2017 Oct; 144():48-52. PubMed ID: 28624517 [TBL] [Abstract][Full Text] [Related]
15. The uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist memantine prolongs spatial memory in a rat delayed radial-arm maze memory task. Wise LE; Lichtman AH Eur J Pharmacol; 2007 Dec; 575(1-3):98-102. PubMed ID: 17850786 [TBL] [Abstract][Full Text] [Related]
16. N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptor. Hurst DP; Lynch DL; Barnett-Norris J; Hyatt SM; Seltzman HH; Zhong M; Song ZH; Nie J; Lewis D; Reggio PH Mol Pharmacol; 2002 Dec; 62(6):1274-87. PubMed ID: 12435794 [TBL] [Abstract][Full Text] [Related]
17. Effects of cannabinoid CB1 receptor antagonist rimonabant in consolidation and reconsolidation of methamphetamine reward memory in mice. Yu LL; Wang XY; Zhao M; Liu Y; Li YQ; Li FQ; Wang X; Xue YX; Lu L Psychopharmacology (Berl); 2009 Jun; 204(2):203-11. PubMed ID: 19148622 [TBL] [Abstract][Full Text] [Related]
18. Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats. Ward SJ; Lefever TW; Rawls SM; Whiteside GT; Walker EA Psychopharmacology (Berl); 2009 Sep; 206(1):155-65. PubMed ID: 19575185 [TBL] [Abstract][Full Text] [Related]